ダウンロード数: 256

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
s41598-017-00917-y.pdf4.69 MBAdobe PDF見る/開く
タイトル: A bacterial ABC transporter enables import of mammalian host glycosaminoglycans
著者: Oiki, Sayoko  kyouindb  KAKEN_id
Mikami, Bunzo  kyouindb  KAKEN_id
Maruyama, Yukie
Murata, Kousaku
Hashimoto, Wataru  kyouindb  KAKEN_id  orcid https://orcid.org/0000-0003-0185-2371 (unconfirmed)
著者名の別形: 老木, 紗予子
村田, 幸作
橋本, 渉
発行日: 21-Apr-2017
出版者: Springer Nature
誌名: Scientific Reports
巻: 7
論文番号: 1069
抄録: Glycosaminoglycans (GAGs), such as hyaluronan, chondroitin sulfate, and heparin, constitute mammalian extracellular matrices. The uronate and amino sugar residues in hyaluronan and chondroitin sulfate are linked by 1, 3-glycoside bond, while heparin contains 1, 4-glycoside bond. Some bacteria target GAGs as means of establishing colonization and/or infection, and bacterial degradation mechanisms of GAGs have been well characterized. However, little is known about the bacterial import of GAGs. Here, we show a GAG import system, comprised of a solute-binding protein (Smon0123)-dependent ATP-binding cassette (ABC) transporter, in the pathogenic Streptobacillus moniliformis. A genetic cluster responsible for depolymerization, degradation, and metabolism of GAGs as well as the ABC transporter system was found in the S. moniliformis genome. This bacterium degraded hyaluronan and chondroitin sulfate with an expression of the genetic cluster, while heparin repressed the bacterial growth. The purified recombinant Smon0123 exhibited an affinity with disaccharides generated from hyaluronan and chondroitin sulfate. X-ray crystallography indicated binding mode of Smon0123 to GAG disaccharides. The purified recombinant ABC transporter as a tetramer (Smon0121-Smon0122/Smon0120-Smon0120) reconstructed in liposomes enhanced its ATPase activity in the presence of Smon0123 and GAG disaccharides. This is the first report that has molecularly depicted a bacterial import system of both sulfated and non-sulfated GAGs.
記述: 細菌によるコンドロイチン分解・吸収機構の実体解明--感染症に対する予防や治療薬の開発に期待--. 京都大学プレスリリース. 2017-04-24.
著作権等: This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
URI: http://hdl.handle.net/2433/222610
DOI(出版社版): 10.1038/s41598-017-00917-y
PubMed ID: 28432302
関連リンク: https://www.kyoto-u.ac.jp/ja/research-news/2017-04-24-0
出現コレクション:学術雑誌掲載論文等

アイテムの詳細レコードを表示する

Export to RefWorks


出力フォーマット 


このリポジトリに保管されているアイテムはすべて著作権により保護されています。